BPG is committed to discovery and dissemination of knowledge
Articles in Press
2/24/2026 10:18:02 AM | Browse: 9 | Download: 0
Publication Name World Journal of Meta-Analysis
Manuscript ID 118496
Country Afghanistan
Category Cardiac & Cardiovascular Systems
Manuscript Type Systematic Reviews
Article Title Adjunctive pharmacologic therapies for diuretic resistance in acute decompensated heart failure: Systematic review of randomized trials
Manuscript Source Unsolicited Manuscript
All Author List Vaishvik Patel, Rabia Zameer, Beesham Kumar and Mehta Das
Funding Agency and Grant Number
Corresponding Author Mehta Das, Department of Internal Medicine, Kabul Medical University, Ataturk Road, Jamal Mina, District 3, Kabul 100310, Afghanistan. mehtadas91@gmail.com
Key Words Acute decompensated heart failure; Diuretic resistance; Adjunctive pharmacologic therapy; Acetazolamide; Thiazide diuretics; Sodium-glucose cotransporter 2 inhibitors; Congestion management; Loop diuretics
Core Tip Diuretic resistance remains a major obstacle to effective decongestion in acute decompensated heart failure (HF). This systematic review synthesizes randomized controlled trial evidence evaluating adjunctive pharmacologic therapies added to loop diuretics. Therapies targeting proximal tubular sodium handling, particularly acetazolamide, consistently improve decongestion and natriuresis without excess renal risk. Thiazide diuretics, which act at the distal convoluted tubule, enhance diuretic response but increase the risk of renal dysfunction and therefore require cautious use. Sodium-glucose cotransporter 2 inhibitors offer modest diuretic effects, reduce worsening HF events, and provide benefits that are not limited by baseline kidney function. In contrast, older adjuncts such as dopamine, nesiritide, and high-dose spironolactone show no clinical benefit in overcoming acute diuretic resistance.
Citation Patel V, Zameer R, Kumar B, Das M. Adjunctive pharmacologic therapies for diuretic resistance in acute decompensated heart failure: Systematic review of randomized trials. World J Meta-Anal 2026; In press
Received
2026-01-04 08:26
Peer-Review Started
2026-01-04 08:28
First Decision by Editorial Office Director
2026-01-21 07:39
Return for Revision
2026-01-21 15:51
Revised
2026-01-30 13:45
Publication Fee Transferred
Second Decision by Editor
2026-02-24 02:47
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2026-02-24 10:18
Articles in Press
2026-02-24 10:18
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 2308-3840 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright ©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com